Sort
21,453 grants matching “tuberculosis”
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$11,078,403Sonal Munsiff · New York City Health/Mental Hygiene · U52 · FY2008 · PS
SDMC: HIV Vaccine Trials Network
$10,940,011Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2016 · AI
SDMC - IMPAACT Leadership Group
$10,912,576David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2019 · AI
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$10,859,273Sonal Munsiff · New York City Health/Mental Hygiene · U52 · FY2009 · PS
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$10,846,231Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2014 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$10,842,162Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI
SDMC - IMPAACT Leadership Group
$10,780,619David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2020 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$10,725,373Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2023 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$10,647,547Sarah Fortune · Harvard School Of Public Health · N01 · FY2019 · AI
SDMC - IMPAACT Leadership Group
$10,340,237David Eric Shapiro · Harvard University D/B/A Harvard School Of Public Health · UM1 · FY2025 · AI
SDMC: HIV Vaccine Trials Network
$10,240,739Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2014 · AI
GH15-1548, Lesotho: Supporting HIV and Tuberculosis Response through District-based Comprehensive Prevention, Care and Treatment Programs and Health Systems Strengthening under PEPFAR
$10,106,584Appolinaire Tiam · Elizabeth Glaser Pediatric Aids Fdn · U2G · FY2016 · GH
UZCHS CTU
$10,064,529Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2019 · AI
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
$10,000,000Judith S. Currier · University Of California Los Angeles · UM1 · FY2022 · AI
CHEMIGENOMIC DRUG DISCOVERY FOR TUBERCULOSIS
$9,962,554President And Fellows Of Harvard College · · FY2017 · Department of the Army
SDMC - IMPAACT Leadership Group
$9,780,448David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2017 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$9,482,062Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2024 · AI
Infectious Diseases Research Technologies Core - Bethesda
$9,451,765Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2011 · AI
Tulane National Primate Research Center
$9,304,973Lee Hamm · Tulane University Of Louisiana · P51 · FY2024 · OD
Tulane National Primate Research Center
$9,304,973Lee Hamm · Tulane University Of Louisiana · P51 · FY2025 · OD
Tulane National Primate Research Center
$9,304,973Lee Hamm · Tulane University Of Louisiana · P51 · FY2023 · OD
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$9,252,840Sarah Fortune · Harvard School Of Public Health · N01 · FY2022 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$9,211,989Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2022 · AI
SDMC - IMPAACT Leadership Group
$9,033,216David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2014 · AI
Infectious Diseases Research Technologies Core - Bethesda
$9,005,342Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2010 · AI